A. Menevşe Et Al. , "CGP52411 an Inhibitor of the EGFR Signalling Pathway Enhances the Chemosensitivity of Laryngeal Squamous Carcinoma Cells to Cisplatin," Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation , Bangkok, Thailand, 2012
Menevşe, A. Et Al. 2012. CGP52411 an Inhibitor of the EGFR Signalling Pathway Enhances the Chemosensitivity of Laryngeal Squamous Carcinoma Cells to Cisplatin. Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation , (Bangkok, Thailand).
Menevşe, A., Ergin, V., Önen, H. İ., & Alp, E., (2012). CGP52411 an Inhibitor of the EGFR Signalling Pathway Enhances the Chemosensitivity of Laryngeal Squamous Carcinoma Cells to Cisplatin . Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation, Bangkok, Thailand
Menevşe, Adnan Et Al. "CGP52411 an Inhibitor of the EGFR Signalling Pathway Enhances the Chemosensitivity of Laryngeal Squamous Carcinoma Cells to Cisplatin," Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation, Bangkok, Thailand, 2012
Menevşe, Adnan Et Al. "CGP52411 an Inhibitor of the EGFR Signalling Pathway Enhances the Chemosensitivity of Laryngeal Squamous Carcinoma Cells to Cisplatin." Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation , Bangkok, Thailand, 2012
Menevşe, A. Et Al. (2012) . "CGP52411 an Inhibitor of the EGFR Signalling Pathway Enhances the Chemosensitivity of Laryngeal Squamous Carcinoma Cells to Cisplatin." Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation , Bangkok, Thailand.
@conferencepaper{conferencepaper, author={Adnan Menevşe Et Al. }, title={CGP52411 an Inhibitor of the EGFR Signalling Pathway Enhances the Chemosensitivity of Laryngeal Squamous Carcinoma Cells to Cisplatin}, congress name={Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation}, city={Bangkok}, country={Thailand}, year={2012}}